Wildcat Capital Management, LLC reported $106,183,289 across 2 13(f) positions for the quarter ended 2026-03-31
Wildcat Capital Management, LLC reported $136,450,563 across 3 13(f) positions for the quarter ended 2025-12-31
Wildcat Capital Management, LLC exited RLX Technology Inc (was $16,879,821, 6,418,183 shares)
Wildcat Capital Management, LLC reported $145,073,911 across 5 13(f) positions for the quarter ended 2025-09-30
Wildcat Capital Management, LLC exited Acuren Corp (was $16,560,000, 1,500,000 shares)
Wildcat Capital Management, LLC exited Urogen Pharma Ltd (was $6,789,802, 495,606 shares)
Wildcat Capital Management, LLC reduced RLX Technology Inc 18,046,195 -> 6,418,183 shares ($39,882,091 -> $16,879,821)
Wildcat Capital Management, LLC reported $168,307,969 across 6 13(f) positions for the quarter ended 2025-06-30
Wildcat Capital Management, LLC exited Centessa Pharmaceuticals Plc (was $4,053,132, 281,859 shares)
Wildcat Capital Management, LLC reported $187,387,580 across 8 13(f) positions for the quarter ended 2025-03-31
Wildcat Capital Management, LLC opened a $16,680,000 position in Acuren Corp (1,500,000 shares)
Wildcat Capital Management, LLC opened a $4,053,132 position in Centessa Pharmaceuticals Plc (281,859 shares)
Wildcat Capital Management, LLC reported $252,705,410 across 8 13(f) positions for the quarter ended 2024-12-31